[1]
F. Boix, “Donor Specific Antibodies Median Fluorescence Intensity Levels Are the Best Indicator for Monitoring Desensitization Treatment in Kidney Transplant”, Urol J, vol. 11, no. 3, pp. 1695–1698, Jul. 2014.